The table below shows Wave Life Sciences Ltd.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$187.49M
-$151.03M
-$19.43M
-$127.78M
-$88.99M
-$115.98M
Capital expenditure
$718.00K
$938.00K
$1.11M
$1.36M
$560.00K
$1.34M
Investing cash flow
-$718.00K
-$938.00K
-$1.11M
-$1.25M
-$560.00K
-$1.34M
Dividends paid
-
-
-
-
WVE operating cash flow (10-K history)
Wave Life Sciences Ltd. reported operating cash flow of -$187.49M for fiscal year 2025. That is down 24.1% from -$151.03M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$31.93M (FY 2016) to -$187.49M. Figures come from the company's audited annual reports as filed with the SEC.
